Quantessence Capital LLC Roivant Sciences Ltd. Transaction History
Quantessence Capital LLC
- $400 Billion
- Q1 2025
A detailed history of Quantessence Capital LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Quantessence Capital LLC holds 12,513 shares of ROIV stock, worth $138,143. This represents 0.03% of its overall portfolio holdings.
Number of Shares
12,513Holding current value
$138,143% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding ROIV
# of Institutions
331Shares Held
496MCall Options Held
3.67MPut Options Held
754K-
Qvt Financial LP New York, NY65.8MShares$726 Million69.8% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X061.9MShares$683 Million5.69% of portfolio
-
Viking Global Investors LP46MShares$508 Million1.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.8MShares$450 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.9MShares$397 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.78B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...